|
BMI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.789600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.403580E-01 |
| Normal-vs-Stage2 |
3.617600E-01 |
| Normal-vs-Stage3 |
9.976100E-02 |
| Normal-vs-Stage4 |
7.981200E-04 |
| Stage1-vs-Stage2 |
8.135000E-01 |
| Stage1-vs-Stage3 |
6.782100E-03 |
| Stage1-vs-Stage4 |
1.2824999999772E-06 |
| Stage2-vs-Stage3 |
5.803900E-02 |
| Stage2-vs-Stage4 |
8.101000E-03 |
| Stage3-vs-Stage4 |
2.919000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.001400E-01 |
| Normal-vs-AfricanAmerican |
2.282800E-01 |
| Normal-vs-Asian |
4.660600E-01 |
| Caucasian-vs-AfricanAmerican |
2.898400E-01 |
| Caucasian-vs-Asian |
3.936400E-01 |
| AfricanAmerican-vs-Asian |
1.805450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.051000E-01 |
| Normal-vs-Female |
8.045200E-01 |
| Male-vs-Female |
9.901200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.339400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.017000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.108200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.872400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.497000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.921000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.800000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.126200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.823800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.399400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.333600E-02 |
| Normal-vs-Grade 2 |
3.858200E-02 |
| Normal-vs-Grade 3 |
2.290300E-02 |
| Normal-vs-Grade 4 |
1.343520E-03 |
| Grade 1-vs-Grade 2 |
5.550400E-01 |
| Grade 1-vs-Grade 3 |
1.192010E-02 |
| Grade 1-vs-Grade 4 |
3.396900E-03 |
| Grade 2-vs-Grade 3 |
3.9475000000011E-05 |
| Grade 2-vs-Grade 4 |
2.46540000004014E-06 |
| Grade 3-vs-Grade 4 |
7.581600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.664100E-02 |
| Normal-vs-ccB subtype |
6.529200E-01 |
| ccA subtype-vs-ccB subtype |
2.326200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.501800E-01 |
| Normal-vs-N1 |
2.529000E-01 |
| N0-vs-N1 |
3.802000E-01 |
|
|
